FIELD: biotechnology.
SUBSTANCE: invention relates to the biotechnology. Described is a method of identifying infectious mononucleosis associated with human herpesvirus type 6 virus, characterized by that in leukocytes of peripheral blood AVR mRNA expression level is detected, 2 CHUK transcript, 2 CIRBP transcript 2, TRAF3 transcript 2 and IRAK4 10 transcript and while increasing AVEN mRNA expression, 2 CHUK transcript, 2 CIRBP transcript, transcript 2 of TRAF3 and reduced expression of 10 IRAK4 transcript, infectious mononucleosis associated with human herpesvirus type 6 is identified.
EFFECT: invention can be used for studying molecular mechanisms of pathogenesis, as well as for clinical diagnosis and monitoring of the disease.
1 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS AETIOLOGY | 2019 |
|
RU2707077C1 |
| METHOD FOR IDENTIFYING INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2732813C1 |
| DIAGNOSTIC TECHNIQUE FOR SEVERE FORM OF THE EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS | 2020 |
|
RU2732012C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING WEB-ASSOCIATED TUMORS IN THE PATIENTS WITH ACUTE EBV-INFECTION | 2019 |
|
RU2707075C1 |
| BIOMARKERS OF DEVELOPING COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2720110C1 |
| METHOD FOR PREDICTION OF SEVERITY OF EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS | 2020 |
|
RU2732010C1 |
| METHOD OF SEARCHING FOR MOLECULAR MARKERS OF A PATHOLOGICAL PROCESS FOR DIFFERENTIAL DIAGNOSIS, MONITORING AND TARGETED THERAPY | 2019 |
|
RU2709815C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF HERPES VIRUS MIXED INFECTION | 2020 |
|
RU2739854C1 |
| PHARMACEUTICAL SALTS OF AMINOBICYCLO[2,2,1]HEPTANE AS NF-KB TRANSCRIPTION FACTOR INHIBITORS WITH ANTIVIRAL ACTIVITY (VERSIONS) AND USING THEM | 2009 |
|
RU2448692C2 |
| METHOD FOR DIAGNOSING BREAST CANCER BY LEVEL OF MRNA TGEβ AND TNFα IN BLOOD PLASMA | 2019 |
|
RU2742209C1 |
